Cardioproteomics: advancing the discovery of signaling mechanisms involved in cardiovascular diseases

被引:0
|
作者
Cui, Ziyou [1 ]
Dewey, Shannamar [1 ,2 ]
Gomes, Aldrin V. [1 ,3 ]
机构
[1] Univ Calif Davis, Dept Neurobiol Physiol & Behav, 176 Briggs Hall,1 Shields Ave, Davis, CA 95616 USA
[2] Univ Calif Davis, Mol Cellular & Integrat Physiol Grad Program, Davis, CA 95616 USA
[3] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA
来源
关键词
Cardioproteomics; cardiovascular diseases; signaling pathway; proteomics; heart; mass spectrometry; drug signaling;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardioproteomics (Cardiovascular proteomics) is fast becoming an indispensible technique in deciphering changes in signaling pathways that occur in cardiovascular diseases (CVDs). The quality and availability of the instruments and bioinformatics software used for cardioproteomics continues to improve, and these techniques are now available to most cardiovascular researchers either directly or indirectly via university core centers. The heart and aorta are specialized tissues which present unique challenges to investigate. Currently, the diverse range of proteomic techniques available for cardiovascular research makes the choice of the best method or best combination of methods for the disease parameter(s) being investigated as important as the equipment used. This review focuses on proteomic techniques and their applications which have advanced our understanding of the signaling mechanisms involved in CVDs at the levels of protein complex/protein-protein interaction, post-translational modifications and signaling induced protein changes.
引用
收藏
页码:274 / 292
页数:19
相关论文
共 50 条
  • [21] FOREBRAIN NEURAL MECHANISMS INVOLVED IN CARDIOVASCULAR REGULATION
    SWANSON, LW
    DEVELOPMENTS IN NEUROSCIENCE, 1982, 15 : 13 - 22
  • [22] CARDIOVASCULAR ACTIONS OF BUFLOMEDIL AND POSSIBLE MECHANISMS INVOLVED
    KUSHIKU, K
    OHBA, M
    MIKAGI, T
    NUKI, S
    ARAKI, Y
    FURUKAWA, T
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1989, 39-1 (06): : 670 - 677
  • [23] CARDIOVASCULAR EFFECTS OF BROVINCAMINE AND POSSIBLE MECHANISMS INVOLVED
    KUSHIKU, K
    KATSURAGI, T
    MORI, R
    FURUKAWA, T
    FOLIA PHARMACOLOGICA JAPONICA, 1983, 82 (02) : P82 - P83
  • [24] MECHANISMS INVOLVED IN THE CARDIOVASCULAR RESPONSE TO TRANSCRANIAL STIMULATION
    COLVILLE, KI
    ELLIS, CH
    KRAMER, AW
    SIVERTSEN, L
    GAHAGAN, LH
    DEBEER, EJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1958, 122 (01): : A13 - A13
  • [25] IMMUNOLOGICAL MECHANISMS INVOLVED IN VIRAL OCULAR DISEASES
    CHANDLER, JW
    OPHTHALMOLOGY, 1980, 87 (12) : 1239 - 1243
  • [26] Epigenetic mechanisms involved in modulation of inflammatory diseases
    Bayarsaihan, Dashzeveg
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2016, 19 (04): : 263 - 269
  • [27] IMMUNOLOGICAL MECHANISMS INVOLVED IN RESPIRATORY TRACT DISEASES
    CARRASCO, E
    GALLEGUILLOS, F
    FUENTESP, E
    REVISTA MEDICA DE CHILE, 1973, 101 (01) : 57 - 66
  • [28] Chronic diseases: Origin and cell mechanisms involved
    Martinez-Puente, David Hernan
    Rodriguez-Roque, Carlos Saul
    Flores-Zavala, Laura Mireya
    Perez-Trujillo, Jose Juan
    Villanueva-Olivo, Arnulfo
    Rodriguez-Rocha, Humberto
    Garcia-Garcia, Aracely
    Saucedo-Cardenas, Odila
    De Oca-Luna, Roberto Montes
    Loera-Arias, Maria de Jesus
    CELLULAR AND MOLECULAR BIOLOGY, 2023, 69 (15) : 26 - 37
  • [29] Signaling mechanisms involved in disuse muscle atrophy
    Zhang, Peng
    Chen, Xiaoping
    Fan, Ming
    MEDICAL HYPOTHESES, 2007, 69 (02) : 310 - 321
  • [30] Endocytic mechanisms and drug discovery in neurodegenerative diseases
    Zhang, Mei
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 : 6086 - 6105